Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Looking ahead, increased competition and the development of oral GLP-1 medications may help improve affordability and accessibility over time, she says
Our findings indicate that the risk of psychiatric outcomes varies across different demographic subgroups
Two discoveries emerged: Combined treatment (GLP-1 drug + anti-CRH) produced greater weight loss and importantly, better weight loss quality, meaning more fat loss and less muscle loss
DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-51088-6 Online ISBN: 978-3-030-51089-3 eBook Packages: MedicineMedicine (R0)
US$ 28.72
US$ 27.84
US$ 20.83
US$ 20.76
US$ 28.54
